Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Nisha-Amalaki add-on to Insulin in Type 1 Diabetes
NCT06487598Active, not recruiting
- Sponsor
- Hirabai Cowasji Jehangir Medical Research Institute
- Start
- Jul 2024
- Primary completion
- Jul 2025
- Countries
- 1
01
Overview
Randomised, open-label trial (2 arms), sponsored by Hirabai Cowasji Jehangir Medical Research Institute. Primary endpoints: Glycemic control (HbA1c) at 3 months and Change in insulin dose at 3 months. Started Jul 2024; status: active, not recruiting.
Beyond the preview
Go deeper on NCT06487598.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT06487598.